Partial Activation of the Factor VIIIa−Factor IXa Enzyme Complex by Dihexanoic Phosphatidylserine at Submicellar Concentrations
- 1 September 1997
- journal article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 36 (35) , 10768-10776
- https://doi.org/10.1021/bi970537y
Abstract
Phosphatidylserine (PS)-containing membranes increase the kcat of the factor VIIIa−factor IXa enzyme complex by more than 1000-fold. While PS supports specific, high-affinity membrane binding of factor VIIIa and factor IXa, it is not known whether PS is the lipid that activates the membrane-bound complex. It is also not known whether PS or other activating lipids must reside in the two-dimensional membrane matrix for efficacy. We have found that submicellar concentrations of dihexanoic phosphatidylserine (C6PS) increase the activity of the factor VIIIa−factor IXa complex in a biphasic manner with half-maximal concentrations of 0.2 and 1.6 mM while the micelle-forming concentration is 4.0 mM. Increased cleavage of factor X at 0.25 mM C6PS was due to a 25-fold enhancement of the kcat and a 30-fold increase in the affinity of factor VIIIa for factor IXa. C6 phosphatidylethanolamine and C6 phosphatidic acid, but not C6 phosphatidylcholine, also accelerated the Xase complex, indicating that kcat enhancement has less structural specificity than membrane binding. Submicellar C6PS enhanced activity of factor IXa in the absence of factor VIIIa, but the effect was due to a decreased KM rather than an increased kcat. These results suggest that activation of the factor VIIIa−factor IXa complex can result from binding of individual C6PS molecules or small aggregates in the absence of a membrane bilayer. They provide a model system in which the phospholipid-induced activation may be distinguished from membrane-binding of the enzyme complex.Keywords
This publication has 13 references indexed in Scilit:
- Identification of the Phospholipid Binding Site in the Vitamin K-dependent Blood Coagulation Protein Factor IXPublished by Elsevier ,1996
- Structural Integrity of the γ-Carboxyglutamic Acid Domain of Human Blood Coagulation Factor IXa Is Required for Its Binding to Cofactor VIIIaPublished by Elsevier ,1996
- Platelet receptor-mediated factor X activation by factor IXa. High-affinity factor IXa receptors induced by factor VIII are deficient on platelets in Scott syndrome.Journal of Clinical Investigation, 1989
- Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid.Journal of Clinical Investigation, 1989
- Expression of coagulant activity in human platelets: Release of membranous vesicles providing platelet factor 1 and platelet factor 3Thrombosis Research, 1985
- Molecular cloning of a cDNA encoding human antihaemophilic factorNature, 1984
- Characterization of the human factor VIII geneNature, 1984
- Coagulation factors V and VIII and ceruloplasmin constitute a family of structurally related proteins.Proceedings of the National Academy of Sciences, 1984
- Isolation and characterization of a cDNA coding for human factor IX.Proceedings of the National Academy of Sciences, 1982
- Interaction of factor VIII-von Willebrand Factor with phospholipid vesiclesBiochemical Journal, 1981